ReviewAnnals of pediatric cardiology
Prevention and control of rheumatic heart disease: Overcoming core challenges in resource-poor environments.
Review in Annals of pediatric cardiology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- Delivering Rheumatic Heart Disease Diagnosis at Scale: Performance of an Integrated Public Health Screening Program in Northern Uganda.Journal of the American Heart Association · 2026Article
- Integrating equity and justice in rheumatic heart disease policy: addressing reproductive health challenges.International journal of public health · 2026Article
- Bayesian Modeling to Project the National and Regional Burden of Rheumatic Heart Disease in Brazil Till 2050.Global heart · 2025Article
- The roles of immuno-modulator treatment and echocardiographic screening in rheumatic fever and rheumatic heart disease control: research from Aotearoa, New Zealand.Journal of the Royal Society of New Zealand · 2025Review
- Outcomes of rheumatic fever in Uganda: a prospective cohort study.The Lancet. Global health · 2024Article
- Temporal Trends and Burden of Rheumatic Heart Disease in South Asia: A Comprehensive Analysis of Three Decades from Global Burden of Disease Study.Global heart · 2024Article
- Development and User Testing of a Dynamic Tool for Rheumatic Heart Disease Management.Applied clinical informatics · 2023Article
- Health-related quality of life and healthcare consultations among adult patients before and after diagnosis with rheumatic heart disease in Namibia.BMC cardiovascular disorders · 2023Article
- Rheumatic heart disease prevalence in Namibia: a retrospective review of surveillance registers.BMC cardiovascular disorders · 2022Article
- Cardiovascular Statistics - Brazil 2021.Arquivos brasileiros de cardiologia · 2022Article
- Rheumatic heart disease in The Gambia: clinical and valvular aspects at presentation and evolution under penicillin prophylaxis.BMC cardiovascular disorders · 2021Article
- Rheumatic Heart Disease Screening Based on Phonocardiogram.Sensors (Basel, Switzerland) · 2021Article
- Preventive interventions to reduce the burden of rheumatic heart disease in populations at risk: a systematic review protocol.Systematic reviews · 2021Article
- Matrix metalloproteinase-9 in pediatric rheumatic heart disease with and without heart failure.Biomedical reports · 2021Article
- Rheumatic Heart Disease is Missing from the Global Health Agenda.Annals of global health · 2021Review
- miRNA-1183-targeted regulation of Bcl-2 contributes to the pathogenesis of rheumatic heart disease.Bioscience reports · 2020Article
- Trends in Deaths from Rheumatic Heart Disease in the Eastern Mediterranean Region: Burden and Challenges.Journal of cardiovascular development and disease · 2018Article
- PASCAR and WHF Cardiovascular Diseases Scorecard project.Cardiovascular journal of AfricaArticle
- Knowledge, attitude, and practice regarding prevention of rheumatic heart disease among primary health-care workers in sokoto metropolis, Sokoto State, Nigeria.Annals of African medicineArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rheumatic heart disease (RHD) has long receded as a significant threat to public health in high-income countries. In low-resource settings, however, the specter of RHD remains unabated, as exemplified by recent data from the Global Burden of Diseases Study. There are many complex reasons for this ongoing global disparity, including inadequate data on disease burden, challenges in effective advocacy, ongoing poverty and inequality, and weak health systems, most of which predominantly affect developing nations. In this review, we discuss how each of these acts as a core challenge in RHD prevention and control. We then examine key lessons learnt from successful control programs in the past and highlight resources that have been developed to help create strong national RHD control programs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.